Publikationen Ratswohl

Publikationen Dr. Christoph Ratswohl

Clamagirand CD, Mallet E, Nieves DJ, Ratswohl C, Owen DM, Rossy J. 2026. Actomyosin rings constrain CD40 mobility to organize the dendritic cell immunological synapse. Cell Commun Signal Apr 18. doi: 10.1186/s12964-026-02816-0. Online ahead of print.
Clamagirand CD, Ratswohl C, Schmid MW, Eich T, Anslinger N, Legler DF, Rossy J. 2026. Distinct dendritic cell cytoskeletal programs dictate synapse architecture and CD8+ T cell fate. Front Immunol Apr 1;17:1716644. doi: 10.3389/fimmu.2026.1716644. eCollection 2026.
Vázquez García C, Obermayer B, Keller B, Lebedin M, Ratswohl C, Abolhassani H, Busse A, Di Virgilio M, Mathas S, Speiser D, Beule D, Pan-Hammarström Q, Warnatz K, de la Rosa K. 2025. Recombination junctions from antibody isotype switching classify immune and DNA repair dysfunction. Nat Commun Dec 19;16(1):11331. doi: 10.1038/s41467-025-67206-5.
Gutjahr JC, Hub E, Anderson CA, Samus M, Artinger K, Gomez EA, Ratswohl C, Wickli N, Raum M, Dufton N, Dalli J, Burden JJ, Duchene J, Rot A. 2025. Intracellular and nuclear CXCR4 signaling promotes terminal erythroblast differentiation and enucleation. Sci Signal Jun 17;18(891):eadt2678. doi: 10.1126/scisignal.adt2678. Epub 2025 Jun 17.
Lebedin M, Ratswohl C, Garg A, Schips M, García CV, Spatt L, Thibeault C, Obermayer B, Weiner J, Velásquez IM, Gerhard C, Stubbemann P, Hanitsch LG, Pischon T, Witzenrath M, Sander LE, Kurth F, Meyer-Hermann M, de la Rosa K. 2024. Soluble ACE2 correlates with severe COVID-19 and can impair antibody responses. iScience Feb 24;27(3):109330. doi: 10.1016/j.isci.2024.109330. eCollection 2024 Mar 15.
Ratswohl C, Vázquez García C, Ahmad AUW, Gonschior H, Lebedin M, Silvis CE, Spatt L, Gerhard C, Lehmann M, Sander LE, Kurth F, Olsson S, de la Rosa K. 2023. A design strategy to generate a SARS-CoV-2 RBD vaccine that abrogates ACE2 binding and improves neutralizing antibody responses. Eur J Immunol Jul 12:e2350408. doi: 10.1002/eji.202350408. Online ahead of print.
Lebedin M, García CV, Spatt L, Ratswohl C, Thibeault C, Ostendorf L, Alexander T, Paul F, Sander LE, Kurth F, de la Rosa K. 2023. Discriminating promiscuous from target-specific autoantibodies in COVID-19. Eur J Immunol May;53(5):e2250210. doi: 10.1002/eji.202250210. Epub 2023 Apr 3.
Lebedin M, Foglierini M, Khorkova S, Vázquez García C, Ratswohl C, Davydov AN, Turchaninova MA, Daubenberger C, Chudakov DM, Lanzavecchia A, de la Rosa K. 2022. Different classes of genomic inserts contribute to human antibody diversity. Proc Natl Acad Sci U S A Sep 6;119(36):e2205470119. doi: 10.1073/pnas.2205470119. Epub 2022 Aug 29.
Meyer-Arndt L, Braun J, Fauchere F, Vanshylla K, Loyal L, Henze L, Kruse B, Dingeldey M, Jürchott K, Mangold M, Maraj A, Braginets A, Böttcher C, Nitsche A, de la Rosa K, Ratswohl C, Sawitzki B, Holenya P, Reimer U, Sander LE, Klein F, Paul F, Bellmann-Strobl J, Thiel A, Giesecke-Thiel C. 2022. SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod. J Neurol Neurosurg Psychiatry Sep;93(9):960-971. doi: 10.1136/jnnp-2022-329395. Epub 2022 Jul 14.
Catakovic K, Gassner FJ, Ratswohl C, Zaborsky N, Rebhandl S, Schubert M, Steiner M, Gutjahr JC, Pleyer L, Egle A, Hartmann TN, Greil R, Geisberger R. 2017. TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia. Oncoimmunology Sep 21;7(1):e1371399. doi: 10.1080/2162402X.2017.1371399. eCollection 2017.